1. A 5-day outpatient regimen of azacitidine is effective and well tolerated in patients with acute myeloid leukemia unsuitable for intensive chemotherapy. Issue 12 (December 2014) Authors: O'Reilly, Maeve A.; McHale, Cathy; Almazmi, Ahmed; Hameed, Abdul; Benjamin, Dalia; O'Connell, Niamh; Murphy, Philip; Quinn, John; Thornton, Patrick; O'Gorman, Peter; Frankova, Hana; Sargent, Jeremy; Verburgh, Estelle; McHugh, John; Evans, Pamela; Enright, Helen Journal: Leukemia & lymphoma Issue: Volume 55:Issue 12(2014:Dec.) Page Start: 2950 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗